| Code | 8950D | ||||||||||
| MA number | EU/1/08/451/005 | ||||||||||
| Product Form: | tbl flm 30x2,5 mg (fľ.HDPE) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| Therapeutic Class: | 58 - HYPOTENSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 21.04.2008 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
GSK DHPC Volibris_26 6 2012.pdf
|
| Safety feature | Yes |
| Data update: | 28.10.2021 |
